Press Releases - 2008

BMT InfoNet webcast
Oct. 2, 2008

Gamida Cell Announces License Agreement with Amgen to Support Development and Commercialization of StemEx® for Hematological Malignancies
Jul. 21, 2008

Gamida Cell Ltd. announced today that the company has executed a licensing agreement with Amgen for the use of a number of proprietary cytokines in the manufacturing of StemEx for Gamida Cell’s pivotal registration study of StemEx and its subsequent commercialization.

Gamida Cell Signs Collaboration Agreement with Biologics Delivery Systems
Jul. 14, 2008

Biologic Delivery Systems will supply catheters for Gamida Cell’s upcoming Phase I/II study of CardioCure™ for heart attack patients.

Press Releases Archive

• Recent
• 2008
• 2007
• 2006
• 2005
• 2004
• 2003

To learn more about our products and clinical trials, please fill in:
*	Name:
*	Email:
	Country:
*	Message:
*	Please type in the verification code as appears on the image: